<p>(A) Western blot of cell lysates from cells treated with <i>para</i>-NO-ASA for the indicated times. Western Blot of caspases-8 (cleaved forms only), -9 (full length, p47 and cleaved forms), caspase-10 (full length only), Bid (full length and cleaved forms) and full length Noxa and Puma are shown. Note that the caspase-8 antibody (#9496) only recognised the cleaved forms and not the intact protein, while the caspase-10 antibody only recognised the full-length form of the protein. (B) NALM6 cells were treated with 5 µM NO-ASA for 6 h and cell lysates analysed for caspase-8 or caspase-9 activity. The mean±SD of 3 experiments is shown. *p<0.05 compared to control. (C) Representative histograms showing <i>para</i>-NO-ASA mediated activation ...
<p>A) A representative Western blot of procaspase and cleaved caspase-8 after 12 hours of treatments...
<p>(A) HeLa cells were treated with 0, 2.5, 5 and 10 mM 3-MA. Cells were collected 0, 1 and 2 days p...
<p>Upper part: cIAP1 and cIAP2 degradation in the MDA-MB-231 cell line after 30 min and 6h of treatm...
<p>(A) The viability (top panel), as determined by 7AAD and annexin V staining, and mitochondrial de...
<p>(A) Cleavage of caspase-3 in NALM6 cells by intracellular flow cytometry following 6 hour exposur...
<p>(A) NALM6 and LK63 cell lines were treated with 10 µM <i>para</i>-NO-ASA for 6 h and labelled for...
<p>Western Blot results after inhibiting either caspase-8 or caspase-9 or both of them. (i, ii) Repr...
<p>(A) H4-APP cells were treated with CPT in the presence and absence of caspase inhibitors for six ...
<p>(A, B) NL20 and A549 cells treated with (lanes 2,4) and without (lanes 1,3) 1 µM STS for 3 hours ...
<p>(A) H4-APP cells were transiently transfected with shRNA to caspase-3 or shRNA to caspase-7 and t...
<p>Capase -8, -9, and -3/-7 activity was measured using a luminometric assay after treatment with va...
<div><p>(A) HeLa cells were infected (+) for 16 h or not (−) and treated for an additional 8 h with ...
<p>The cells were pre-incubated for 1 h individually with 100 µM pan caspase-inhibitor Z-VAD-fmk, ca...
<p>(<b>A</b>) SH-EP1 cells transfected with control vector (Ctl) or DN-Cas4 expression vector (DN-Ca...
<p>(A) The relative RNA expression level of caspase-3 in SAS cell treated with indicated dosages of ...
<p>A) A representative Western blot of procaspase and cleaved caspase-8 after 12 hours of treatments...
<p>(A) HeLa cells were treated with 0, 2.5, 5 and 10 mM 3-MA. Cells were collected 0, 1 and 2 days p...
<p>Upper part: cIAP1 and cIAP2 degradation in the MDA-MB-231 cell line after 30 min and 6h of treatm...
<p>(A) The viability (top panel), as determined by 7AAD and annexin V staining, and mitochondrial de...
<p>(A) Cleavage of caspase-3 in NALM6 cells by intracellular flow cytometry following 6 hour exposur...
<p>(A) NALM6 and LK63 cell lines were treated with 10 µM <i>para</i>-NO-ASA for 6 h and labelled for...
<p>Western Blot results after inhibiting either caspase-8 or caspase-9 or both of them. (i, ii) Repr...
<p>(A) H4-APP cells were treated with CPT in the presence and absence of caspase inhibitors for six ...
<p>(A, B) NL20 and A549 cells treated with (lanes 2,4) and without (lanes 1,3) 1 µM STS for 3 hours ...
<p>(A) H4-APP cells were transiently transfected with shRNA to caspase-3 or shRNA to caspase-7 and t...
<p>Capase -8, -9, and -3/-7 activity was measured using a luminometric assay after treatment with va...
<div><p>(A) HeLa cells were infected (+) for 16 h or not (−) and treated for an additional 8 h with ...
<p>The cells were pre-incubated for 1 h individually with 100 µM pan caspase-inhibitor Z-VAD-fmk, ca...
<p>(<b>A</b>) SH-EP1 cells transfected with control vector (Ctl) or DN-Cas4 expression vector (DN-Ca...
<p>(A) The relative RNA expression level of caspase-3 in SAS cell treated with indicated dosages of ...
<p>A) A representative Western blot of procaspase and cleaved caspase-8 after 12 hours of treatments...
<p>(A) HeLa cells were treated with 0, 2.5, 5 and 10 mM 3-MA. Cells were collected 0, 1 and 2 days p...
<p>Upper part: cIAP1 and cIAP2 degradation in the MDA-MB-231 cell line after 30 min and 6h of treatm...